UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Acute severe cardiac failure in a myeloma patient due to proteasome inhibitor bortezomib

International journal of hematology, 2008-09, Vol.88 (2), p.219-222

2008

Volltextzugriff (PDF)

Programmed Cell Death Ligand 1 Expression Level and Prognostic Significance in Acute Myeloid Leukemia

Indian journal of hematology & blood transfusion, 2022-07, Vol.38 (3), p.464-472

2022

Volltextzugriff (PDF)

Correction to: Efects of AGEs, sRAGE and HMGB1 on Clinical Outcomes in Multiple Myeloma

Indian journal of hematology & blood transfusion, 2023-07, Vol.39 (3), p.518-518

2023

Volltextzugriff (PDF)

Prognostic Value of Serum Soluble Klotho and Fibroblast Growth Factor-23 in Multiple Myeloma Patients

Indian journal of hematology & blood transfusion, 2022-07, Vol.38 (3), p.454-463

2022

Volltextzugriff (PDF)

Serum hepcidin and growth differentiation factor-15 (GDF-15) levels in polycythemia vera and essential thrombocythemia

European journal of haematology, 2013-09, Vol.91 (3), p.228-235

2013

Volltextzugriff (PDF)

Serum Growth Differentiation Factor 15 Levels in Newly Diagnosed Multiple Myeloma Patients

Acta haematologica, 2014-01, Vol.131 (3), p.173-178

2014

Volltextzugriff (PDF)

Late-onset Anticonvulsant Hypersensitivity Syndrome Mimicking Lymphoma

Internal Medicine, 2015, Vol.54(24), pp.3201-3204

2015

Volltextzugriff (PDF)

The Plasminogen Activator System in Young and Lean Women with Polycystic Ovary Syndrome

Endocrine Journal, 2004, Vol.51(5), pp.467-472

2004

Volltextzugriff (PDF)

Do Alarmins Have a Role in Multiple Myeloma?

Turkish journal of haematology, 2024-05, Vol.41 (2), p.83-90

2024

Volltextzugriff (PDF)

Evaluation of a Generic Bortezomib Molecule in Newly Diagnosed Multiple Myeloma Patients

Turkish journal of haematology, 2021-01, Vol.38 (3), p.211-217

2021

Volltextzugriff (PDF)

Dasatinib-induced immune mediated-thrombotic thrombocytopenic purpura

Transfusion and apheresis science, 2018-04, Vol.57 (2), p.222-224

2018

Volltextzugriff (PDF)

Soluble Programmed Death 1 (PD-1) Is Decreased in Patients With Immune Thrombocytopenia (ITP): Potential Involvement of PD-1 Pathway in ITP Immunopathogenesis

Clinical and applied thrombosis/hemostasis, 2016-04, Vol.22 (3), p.248-251

2016

Volltextzugriff (PDF)

Effects of AGEs, sRAGE and HMGB1 on Clinical Outcomes in Multiple Myeloma

Indian journal of hematology & blood transfusion, 2023-04, Vol.39 (2), p.220-227

2023

Volltextzugriff (PDF)

Hematolojik Maligniteli Nötropenik Hastalarda Daptomisin Tedavisinin Etkinligi/Effectiveness of Daptomycin Therapy in Neutropenic Patients with Haematological Malignancies

KLIMIK dergisi, 2015-08, Vol.28 (2), p.72

2015

Volltextzugriff (PDF)

The Plasminogen Activator System in Young and Lean Women with Polycystic Ovary Syndrome

ENDOCRINE JOURNAL, 2004, Vol.51 (5), p.467-472

2004

Volltextzugriff (PDF)

Treatment of patients with multiple myeloma over 65 yr: more tolerability or better response?

European journal of haematology, 2015-05, Vol.94 (5), p.424-430

2015

Volltextzugriff (PDF)

The Role of β-Catenin in Bcr/Abl Negative Myeloproliferative Neoplasms: An Immunohistochemical Study

Clinical lymphoma, myeloma and leukemia, 2015-12, Vol.15 (12), p.785-789

2015

Volltextzugriff (PDF)

The role of hepcidin, GDF15, and mitoferrin-1 in iron metabolism of polycythemia vera and essential thrombocytosis patients

TURKISH JOURNAL OF MEDICAL SCIENCES, 2019-02, Vol.49 (1), p.74-80

2019

Volltextzugriff (PDF)

Is the autologous stem cell transplantation cardiotoxic or cardioprotective in patients with multiple myeloma ?

Kocaeli Medical Journal, 2020, Vol.9 (3), p.8-13

2020

Volltextzugriff (PDF)

Decreased serum heat shock protein 60 levels in newly diagnosed immune thrombocytopenia patients

Platelets (Edinburgh), 2015-01, Vol.26 (3), p.220-223

2015

Volltextzugriff (PDF)

Serum Angiopoietin Levels are Different in Acute and Chronic Myeloid Neoplasms: Angiopoietins do not only Regulate Tumor Angiogenesis

Indian journal of hematology & blood transfusion, 2016-06, Vol.32 (2), p.162-167

2016

Volltextzugriff (PDF)

Soluble Programmed Death 1 (PD-1) Is Decreased in Patients With Immune Thrombocytopenia (ITP)

Clinical and applied thrombosis/hemostasis, 2016-04, Vol.22 (3), p.248-251

2016

Volltextzugriff (PDF)

Use of recombinant factor VIIa in the management and prophylaxis of bleeding episodes in two patients with Bernard–Soulier syndrome

Thrombosis research, 2007, Vol.120 (3), p.455-457

2007

Volltextzugriff (PDF)

Pralatrexate-Induced Toxic Epidermal Necrolysis

Uluslararası hematologi-onkoloji dergisi, 2017-01, Vol.27 (4), p.253-255

DEMIRSOY, ESRA TERZI

2017

Volltextzugriff (PDF)

1 – 25 von 56

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(48)
Mit Volltextzugriff
(47)

Publikationsform

Artikel
(54)
Berichte
(2)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Acute severe cardiac failure in a myeloma patient due to proteasome inhibitor bortezomib

Programmed Cell Death Ligand 1 Expression Level and Prognostic Significance in Acute Myeloid Leukemia

Correction to: Efects of AGEs, sRAGE and HMGB1 on Clinical Outcomes in Multiple Myeloma

Prognostic Value of Serum Soluble Klotho and Fibroblast Growth Factor-23 in Multiple Myeloma Patients

Serum hepcidin and growth differentiation factor-15 (GDF-15) levels in polycythemia vera and essential thrombocythemia

Serum Growth Differentiation Factor 15 Levels in Newly Diagnosed Multiple Myeloma Patients

Late-onset Anticonvulsant Hypersensitivity Syndrome Mimicking Lymphoma

The Plasminogen Activator System in Young and Lean Women with Polycystic Ovary Syndrome

Do Alarmins Have a Role in Multiple Myeloma?

Evaluation of a Generic Bortezomib Molecule in Newly Diagnosed Multiple Myeloma Patients

Dasatinib-induced immune mediated-thrombotic thrombocytopenic purpura

Soluble Programmed Death 1 (PD-1) Is Decreased in Patients With Immune Thrombocytopenia (ITP): Potential Involvement of PD-1 Pathway in ITP Immunopathogenesis

Effects of AGEs, sRAGE and HMGB1 on Clinical Outcomes in Multiple Myeloma

Hematolojik Maligniteli Nötropenik Hastalarda Daptomisin Tedavisinin Etkinligi/Effectiveness of Daptomycin Therapy in Neutropenic Patients with Haematological Malignancies

The Plasminogen Activator System in Young and Lean Women with Polycystic Ovary Syndrome

Treatment of patients with multiple myeloma over 65 yr: more tolerability or better response?

The Role of β-Catenin in Bcr/Abl Negative Myeloproliferative Neoplasms: An Immunohistochemical Study

The role of hepcidin, GDF15, and mitoferrin-1 in iron metabolism of polycythemia vera and essential thrombocytosis patients

The Role of Azacitidine in the Treatment of Elderly Patients with Acute Myeloid Leukemia: Results of a Retrospective Multicenter Study

Is the autologous stem cell transplantation cardiotoxic or cardioprotective in patients with multiple myeloma ?

Decreased serum heat shock protein 60 levels in newly diagnosed immune thrombocytopenia patients

Serum Angiopoietin Levels are Different in Acute and Chronic Myeloid Neoplasms: Angiopoietins do not only Regulate Tumor Angiogenesis

Soluble Programmed Death 1 (PD-1) Is Decreased in Patients With Immune Thrombocytopenia (ITP)

Use of recombinant factor VIIa in the management and prophylaxis of bleeding episodes in two patients with Bernard–Soulier syndrome

Pralatrexate-Induced Toxic Epidermal Necrolysis

Suchergebnisse filtern